Rate My Professor Diane Rebourcet

Rebourcet's research specializes in reproductive biology, with a focus on testis development and function, particularly the roles of Sertoli cells in regulating Leydig cell differentiation and androgen production via classical and alternative pathways. Her work explores endocrine disruptors' impacts, biotechnological applications like gene therapy, and Sertoli cells as therapeutic targets for male reproductive disorders. She utilizes transgenic mouse models, in silico modeling, and biomolecular techniques. Notable collaborations include researchers from the University of Glasgow, University of Edinburgh, University of Geneva, and Hudson Institute of Medical Research.

Her key publications encompass "Functional Analysis of HSD17B3-Deficient Male Mice Reveals Roles for HSD17B7 and HSD17B12 in Testosterone Biosynthesis" (Endocrinology, 2025), "Compensatory mechanisms that maintain androgen production in mice lacking key androgen biosynthetic enzymes" (FASEB Journal, 2024), "Development of peptides for targeting cell ablation agents concurrently to the Sertoli and Leydig cell populations of the testes: An approach to non-surgical sterilization" (PLOS ONE, 2024), "Sertoli cell-enriched proteins in mouse and human testicular interstitial fluid" (PLOS ONE, 2023), and chapters such as "Sertoli Cell" (2026). Rebourcet has been recognized with a Society for Endocrinology travel grant in 2016 and served as a keynote speaker in 2018 on Sertoli cell ablation effects. Her research has garnered over 1,450 citations, advancing knowledge in endocrinology and reproductive sciences.